SYNGENE INTERNATIONAL
|
SYNGENE INTERNATIONAL Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 12.33 | 12.69 | 11.57 | 9.88 | 10.12 |
| CEPS(Rs) | 23.08 | 23.28 | 20.70 | 17.60 | 16.99 |
| DPS(Rs) | 1.25 | 1.25 | 1.25 | 1.00 | - |
| Book NAV/Share(Rs) | 115.46 | 104.19 | 88.51 | 80.09 | 68.61 |
| Tax Rate(%) | 24.81 | 17.85 | 21.77 | 18.29 | 13.70 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 28.49 | 29.05 | 29.18 | 28.43 | 29.90 |
| EBIT Margin(%) | 19.50 | 19.13 | 19.98 | 19.53 | 22.75 |
| Pre Tax Margin(%) | 18.05 | 17.78 | 18.57 | 18.60 | 21.48 |
| PAT Margin (%) | 13.57 | 14.60 | 14.53 | 15.20 | 18.54 |
| Cash Profit Margin (%) | 25.40 | 26.80 | 25.99 | 27.09 | 31.10 |
| Performance Ratios | |||||
| ROA(%) | 7.71 | 8.59 | 8.25 | 7.69 | 9.17 |
| ROE(%) | 11.23 | 13.18 | 13.73 | 13.29 | 16.59 |
| ROCE(%) | 15.42 | 15.55 | 15.43 | 13.24 | 15.40 |
| Asset Turnover(x) | 0.57 | 0.59 | 0.57 | 0.51 | 0.49 |
| Sales/Fixed Asset(x) | 0.72 | 0.74 | 0.76 | 0.71 | 0.69 |
| Working Capital/Sales(x) | 4.10 | 4.29 | 2.58 | 2.67 | 3.24 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.39 | 1.35 | 1.31 | 1.40 | 1.46 |
| Receivable days | 48.32 | 50.73 | 59.21 | 68.92 | 73.02 |
| Inventory Days | 19.66 | 29.85 | 29.24 | 16.75 | 7.09 |
| Payable days | 6,521.69 | 1,652.80 | -2,132.64 | -4,008.24 | -3,357.42 |
| Valuation Parameters | |||||
| PER(x) | 58.90 | 55.31 | 51.39 | 60.44 | 53.68 |
| PCE(x) | 31.47 | 30.14 | 28.72 | 33.91 | 31.99 |
| Price/Book(x) | 6.29 | 6.73 | 6.72 | 7.45 | 7.92 |
| Yield(%) | 0.17 | 0.18 | 0.21 | 0.17 | - |
| EV/Net Sales(x) | 7.84 | 7.96 | 7.49 | 9.29 | 10.01 |
| EV/Core EBITDA(x) | 25.64 | 25.15 | 23.78 | 28.50 | 29.69 |
| EV/EBIT(x) | 40.05 | 41.60 | 37.43 | 47.58 | 44.00 |
| EV/CE(x) | 5.89 | 6.32 | 5.70 | 4.40 | 4.56 |
| M Cap / Sales | 8.02 | 8.09 | 7.47 | 9.19 | 9.95 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 4.41 | 9.26 | 22.61 | 19.22 | 8.57 |
| Core EBITDA Growth(%) | 0.78 | 9.92 | 18.42 | 15.28 | 5.28 |
| EBIT Growth(%) | 6.74 | 4.57 | 25.62 | 2.33 | -9.90 |
| PAT Growth(%) | -2.71 | 9.82 | 17.33 | -2.25 | -1.75 |
| EPS Growth(%) | -2.83 | 9.66 | 17.16 | -2.44 | -1.75 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.03 | 0.16 | 0.25 | 0.28 |
| Current Ratio(x) | 1.64 | 1.71 | 2.04 | 1.80 | 1.59 |
| Quick Ratio(x) | 1.53 | 1.50 | 1.76 | 1.65 | 1.55 |
| Interest Cover(x) | 13.43 | 14.15 | 14.13 | 21.10 | 17.94 |
| Total Debt/Mcap(x) | - | 0.01 | 0.02 | 0.03 | 0.04 |
Compare Financial Ratios of peers of SYNGENE INTERNATIONAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNGENE INTERNATIONAL | ₹27,246.1 Cr | 2.5% | 6.3% | -14.3% | Stock Analytics | |
| SAGILITY INDIA | ₹20,368.5 Cr | -2.5% | 9% | NA | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹9,196.9 Cr | 0.2% | 7.5% | -18.5% | Stock Analytics | |
| JUST DIAL | ₹7,362.7 Cr | -7.5% | -0.7% | -28.8% | Stock Analytics | |
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,108.0 Cr | -0.7% | 3% | -30.3% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹4,527.2 Cr | 1.5% | -1.5% | -7.5% | Stock Analytics | |
SYNGENE INTERNATIONAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNGENE INTERNATIONAL | 2.5% |
6.3% |
-14.3% |
| SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses
